Virgin Atlantic customers flying to Barbados or onwards to Antigua and Grenada on selected flights will receive a free, rapid, point of care, pre-departure lateral flow antigen test at Heathrow.
Launching on December 9th, the move is part of an airline-led trial to gather vital data on the logistics and effectiveness of pre-departure testing.
Virgin Atlantic continues to lead the way with industry in calling for the introduction of a robust pre-departure regime, to swiftly and safely replace the new UK ‘test and release’ scheme commencing December 15th.
The trial initiative, six weeks in duration, will further demonstrate the deliverability of a pre-departure testing regime at scale, offering real-world data for these popular leisure routes as UK travel restrictions for non-essential travel ease as of December 3rd.
Industry-led trials at London Heathrow support the latest independent analysis by Oxera and Edge Health which shows that all forms of passenger testing would be more effective than the current 14-day quarantine.
Shai Weiss, chief executive of Virgin Atlantic, said: “The new UK test to release scheme is a vital first step in re-opening the skies, but we must now move rapidly towards a single test pre-departure regime in order to ensure the